Our scientific advisors

Our Grant Review Board ensure that we only fund the best research that will take us closer to effective diagnostics, preventions and treatments for dementia.

Grant Review Board

Our Grant Review Board ensure that we only fund the best research that will take us closer to effective diagnostics, preventions and treatments for dementia.

We are currently recruiting new researchers to join our Grant Review Board. Find out more information here.

Stuart Pickering Brown

Prof Stuart Pickering-Brown

Prof Pickering-Brown is the Chair of our Grant Review Board. Based at the University of Manchester, he researches the genetics underpinning frontotemporal dementia.

Bettina Platt

Prof Bettina Platt

Prof Platt is based at the University of Aberdeen. Her research focuses on trying to understand the biological pathways triggered when nerve cells are damaged in Alzheimer’s.

Robert Williams

Dr Robert Williams

Dr Williams is based at the University of Bath and is interested in the break-down in communication between nerve cells and how this can be stopped.

Andy Randall

Prof Andy Randall

Prof Randall is based at the University of Exeter. He is particularly interested in how nerve cell activity is altered in Alzheimer’s disease.

John O'Brien

Prof John O’Brien

Prof O’Brien is a clinician based at the University of Cambridge. His wants to develop better brain imaging tools to help diagnose dementia.

Lesley Jones

Prof Lesley Jones

Prof Jones is based at the University of Cardiff. Her work involves understanding the biological pathways altered by different genetic risk factors for Alzheimer’s. Prof Jones leads the Alzheimer’s Research UK Cardiff Research Network.

Andrew Doig

Prof Andrew Doig

Prof Doig is based at the University of Manchester. He is trying to develop new ways to stop the toxic build-up of proteins in the brains of people with Alzheimer’s.

Our scientific advisors

Prof Nick Fox

Prof Fox is a neurologist based at University College London. He uses brain imaging techniques to improve dementia diagnosis and monitor disease progression.

Tara Spiers-Jones

Dr Tara Spires-Jones

Dr Spires-Jones is based at the University of Edinburgh. She studies how toxic proteins in Alzheimer’s disrupt nerve cell communication.

Johannes Atternes

Prof Johannes Attems

Prof Attems is based at the University of Newcastle. He uses donated brain tissue to understand more about the biological changes that occur in Alzheimer’s. You can learn more about brain donation on the blog.

Clive Holmes

Prof Clive Holmes

Prof Holmes is a clinician based at the University of Southampton. His work focuses on understanding how the immune system is involved in the progression of Alzheimer’s.

James Nicholl

Prof James Nicoll

Prof Nicoll is based at the University of Southampton and researchers how inflammation and blood supply to the brain are altered in dementia.

Jill Richardson

Dr Jill Richardson

Dr Richardson is a Director at the pharmaceutical company GlaxoSmithKline. She oversees the development of drugs for Alzheimer’s.

Rick Livesy

Prof Rick Livesey

Prof Livesey is based at the University of Cambridge and heads the Alzheimer’s Research UK Stem Cell Research Centre.

Simon Mead

Prof Simon Mead

Prof Mead is a clinician based at University College London. His work focuses on the genetics underpinning different forms of dementia.

Michael Coleman

Dr Michael Coleman

Prof Coleman is based at the University of Cambridge. He researches nerve cell damage and how the transport of biological molecules changes with age. He also leads the Alzheimer’s Research UK Cambridge Research Network.

Karen Ritchie

Prof Karen Ritchie

Prof Ritchie is based at Imperial College London. She is interested in how lifestyle factors increase dementia risk. This type of research requires lots of volunteers. You can find out more about getting involved in research with the ‘Join dementia research’ scheme.

Our scientific advisors

Dr Mike O'Neill

Dr O’Neill is Head of the Neurodegeneration Group at the pharmaceutical company Lily. He leads a group of researchers investigating new treatments for Alzheimer’s.